These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3475830)

  • 1. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
    Zakharova GN; Bulkin VA
    Stomatologiia (Mosk); 1987; 66(3):37-9. PubMed ID: 3475830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS; Faizov TT; Berim MG
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of proteolytic enzymes in the treatment of acute suppurative diseases of the maxillo-facial area].
    Protasevich AI
    Vestn Khir Im I I Grek; 1969 Mar; 102(3):83-5. PubMed ID: 5358819
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
    Alekhova TM
    Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ways to prevent and treat disseminated inflammatory diseases of the maxillofacial area and their complications].
    Robustova TG; Gubin MA; Tsarev VN; Lebedev KA; Ushakov RV; Starodubtsev VS; Fomichev EV
    Stomatologiia (Mosk); 1995; 74(1):31-3. PubMed ID: 7770875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
    Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with the treatment of children with suppurative inflammatory processes in the maxillofacial region].
    Chmyrev VS
    Stomatologiia (Mosk); 1974; 53(4):49-51. PubMed ID: 4529134
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area].
    Bernadskaia GP; Timofeev AA; Kutsenko TA
    Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of netromycin in suppurative maxillofacial surgery in children].
    Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA
    Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723
    [No Abstract]   [Full Text] [Related]  

  • 10. [The optimization of the regeneration of a suppurative wound in the maxillofacial area by using lymphogenic therapy].
    Shumskiĭ AV; Pozdniĭ AIu; Morozov PV
    Voen Med Zh; 1999 May; 320(5):28-33. PubMed ID: 10401246
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of patients with phlegmon of the maxillofacial area using a levomecol ointment].
    Chernoglazova EM
    Stomatologiia (Mosk); 1987; 66(5):42-4. PubMed ID: 3480633
    [No Abstract]   [Full Text] [Related]  

  • 12. [New antimicrobial preparations in the overall treatment of suppurative inflammatory processes in the maxillofacial area].
    Solomennyĭ SM; Paliĭ GK; Burdeniuk IP
    Stomatologiia (Mosk); 1979; 58(2):39-41. PubMed ID: 375477
    [No Abstract]   [Full Text] [Related]  

  • 13. [The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives].
    Ushakov RV; Tsarev VN; Dugarov BD; Lopyrev VA
    Stomatologiia (Mosk); 1992; (3-6):31-4. PubMed ID: 1307150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An analysis of the mortality of patients with suppurative-inflammatory diseases of the maxillofacial area].
    Karshiev KhK
    Stomatologiia (Mosk); 1997; 76(5):9-10. PubMed ID: 9411944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of preparations with antioxidant action in the combined treatment of phlegmons of the maxillofacial area].
    Ragimov ChR
    Stomatologiia (Mosk); 1992; (3-6):35-7. PubMed ID: 1307152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The endogenous intoxication syndrome and the procedure for detoxication therapy in the treatment of suppurative diseases of the face and neck].
    Gubin MA; Kharitonov IuM; El'kova NL; Korolinskiĭ SA; Motorin SA; Stegantsov VA
    Stomatologiia (Mosk); 1996; 75(4):23-7. PubMed ID: 8992658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maxillofacial inflammatory diseases of odontogenic origin in pregnant women].
    Ugrinov R
    Stomatologiia (Sofiia); 1977; 59(5):345-9. PubMed ID: 292239
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR
    Sov Med; 1991; (7):29-31. PubMed ID: 1948337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute inflammatory processes in the maxillofacial region and neck in diabetics].
    Gubin MA; Popov NG; Gubina LK; Sergienko ET
    Stomatologiia (Mosk); 1975; 54(2):44-6. PubMed ID: 1055486
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mediastinitis--a severe complication of acute odontogenic inflammatory processes of the maxillofacial area].
    Nikitin AA; Kosiakov MN; Nevrov AN; Rubtsov IA; Lapshin VP; Zhdanov EV
    Stomatologiia (Mosk); 1996; Spec No():70-1. PubMed ID: 9281168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.